Contributors
Latest:
Helping Patients Navigate the Clinical Trial SpaceThe Leukemia & Lymphoma Society's (LLS) Clinical Trial Support Center helps patients with blood cancers find clinical trials that are right for them.
Latest:
ADT May Offer Some Protection From COVID-19 in Men with Prostate CancerA PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.
Latest:
Addressing Questions From Newly Diagnosed Patients with Multiple MyelomaNaturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.
Latest:
Speaking Out: Some Cancer Screenings Can Lead to Unnecessary TreatmentThe extent of overdiagnosis in cancer differs according to the tumor type, its biology and the screening test.
Latest:
There's Only One Time to Treat Cancer the First TimeAs more treatment options become availabe in the cancer space, it may be difficult for patients and their caregivers to decide on the best plan of action. Maggie Row, M.D. offers her advice.
Latest:
Our Sisters' KeepersEverything about the words “breast cancer” is dark, sad and scary. When you add “metastatic” (stage 4) to those words, there comes an uncontrollable fear that encompasses the mind. To help people cope with this, four African American women started on a journey to educate women of color about the effects and importance of understanding breast cancer.
Latest:
Danielle Nicosia on Being MisdiagnosedDanielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.
Latest:
Prostate Cancer: To Treat or Not to TreatWe've come a long way in determining which patients with prostate cancer to treat, but there is still more work that needs to be done.
Latest:
MPN Hero Advocates For Patients Enrolled In Clinical TrialsKurt Schroeder, a research nurse, pushes for a patient-first mentality, especially as they participate in a clinical trial.
Latest:
How My Cancer Nurse Made Each and Every Day CountAn Extraordinary Healers essay honoring Kathryn “Kitty” Vance, RN, BSN [LCI Radiation Therapy in Pineville, North Carolina]
Latest:
Understanding the Role of Immunoglobulins in Multiple MyelomaAt CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.
Latest:
Holding Our Mission -- and Her Oncology Patients -- in Her HeartAn Extraordinary Healer essay honoring Carolyn Harshbarger, BSN, RN, OCN [ St. Vincent Health in Indianapolis, Indiana ]
Latest:
Cancer Helped Me Choose KindnessMy cancer diagnosis — and the emotional effects that came with it — made me who I am today.
Latest:
By My Side Through Cancer TreatmentsAn Extraordinary Healer essay honoring THERESA WILLIAMS, RN, OCN [SUMMIT CANCER CARE, SAVANNAH, GEORGIA]
Latest:
Understanding Cancer's Financial LandscapeAshley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.
Latest:
Step InsideLatest:
Mark Malkin Discusses Using Viruses to Treat Brain CancerMark G. Malkin, M.D., professor of Neurology at the Virginia Commonwealth University, discusses the possibility of using viruses to treat glioblastoma.
Latest:
Lynne Joy Malestic Discusses Her Transition to Oncology NursingLynne Joy Malestic, RN, Eisenhower Lucy Curci Cancer Center, Rancho Mirage, California, 2016 Extraordinary Healer Award Winner, discusses how she entered oncology nursing after 15 years in obstetrics.
Latest:
Rintega Receives Breakthrough Designation for EGFRvIII-Positive GlioblastomaRintega (rindopepimut) has gained a Breakthrough Therapy Designation from the FDA to treat adult patients with glioblastoma multiforme (GBM) that test positive for the EGFR variant (EGFRvIII).
Latest:
Anya Prince on Insurance Coverage for Preventative ServicesAnya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.
Latest:
The PatientLatest:
Testing for RecurrenceEarly-stage colorectal cancer patients may benefit from a new test that predicts their risk of recurrence.
Latest:
NCODA Welcomes Three New Executive Council MembersThe National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of three new members to the Executive Council.
Latest:
Combination Therapies Open New Doors in Renal Cell Carcinoma StudiesUtilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
Latest:
My Secret Life With Ovarian Cancer“For so long ovarian cancer has been a secret part of my life. That’s over now.”
Latest:
Unlocking the Mystery of Cancer Stem CellsScientists research whether cancer stem cells are the key to eradicating the disease.
Latest:
Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes StatusPatients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes mellitus status.
Latest:
Granting Wishes for Pediatric PatientsAll the wishes granted at Make-A-Wish New Jersey are special, from meet and greets with A-list celebrities, to smaller wishes that are just as meaningful.
